| Cat. No. |
Product |
Quantity/Size |
Price |
Data |
|
| RVV08808A |
Human Anti-HPV16 L1/Major capsid protein L1 (H16.14J) mAb |
100 µg |
$475.00
|
 |
BUY
|
| RVV08808B |
Human Anti-HPV16 L1/Major capsid protein L1 (H16.14J) mAb |
1.0 mg |
$2,135.00
|
|
BUY
|
| RVV08804A |
Human Anti-HPV16 L1/Major capsid protein L1 (H16.U4) mAb |
100 µg |
$475.00
|
|
BUY
|
| RVV08804B |
Human Anti-HPV16 L1/Major capsid protein L1 (H16.U4) mAb |
1.0 mg |
$2,135.00
|
|
BUY
|
| FHF90710B |
Human Anti-Human ROR1 (SAA0140) mAb |
100 ug |
$430.00
|
|
BUY
|
| FHF90710C |
Human Anti-Human ROR1 (SAA0140) mAb |
1.0 mg |
$1,565.00
|
|
BUY
|
| FHF90710A |
Human Anti-Human ROR1 (SAA0140) mAb |
50 ug |
$300.00
|
|
BUY
|
| CPC539C |
Human Anti-SARS-CoV-2 Spike-RBD Bebtelovimab (LY-CoV1404 / LY3853113) Neutralizing mAb |
1.0 mg |
Please Inquire |
|
BUY
|
| CPC539A |
Human Anti-SARS-CoV-2 Spike-RBD Bebtelovimab (LY-CoV1404 / LY3853113) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC539B |
Human Anti-SARS-CoV-2 Spike-RBD Bebtelovimab (LY-CoV1404 / LY3853113) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC541B |
Human Anti-SARS-CoV-2 Spike-RBD Neutralizing (S2E12) mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC541C |
Human Anti-SARS-CoV-2 Spike-RBD Neutralizing (S2E12) mAb |
1.0 mg |
Please Inquire |
|
BUY
|
| CPC541A |
Human Anti-SARS-CoV-2 Spike-RBD Neutralizing (S2E12) mAb |
50 µg |
Please Inquire |
|
BUY
|
| FHB65410A |
Humanized Anti-Human SLC34A2 / NaPi2b (SAA0766) mAb |
100 ug |
$330.00
|
|
BUY
|
| FHB65410B |
Humanized Anti-Human SLC34A2 / NaPi2b (SAA0766) mAb |
1.0 mg |
$1,562.00
|
|
BUY
|
| FHJ04020A |
Mouse Anti-Human CD276 (Mab 8H9) mAb |
100 ug |
$475.00
|
|
BUY
|
| FHJ04020B |
Mouse Anti-Human CD276 (Mab 8H9) mAb |
1.0 mg |
$1,562.00
|
|
BUY
|
| FMJ04020A |
Rat Anti-Mouse/Human CD276 / B7-H3 (m276) mAb |
50 ug |
$280.00
|
|
BUY
|
| FMJ04020B |
Rat Anti-Mouse/Human CD276 / B7-H3 (m276) mAb |
100 ug |
$475.00
|
|
BUY
|
| DXX00201B |
Research Grade Actoxumab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DXX00201A |
Research Grade Actoxumab |
100 µg |
$420.00
|
|
BUY
|
| DHH28807A |
Research Grade Afasevikumab |
100 ug |
$380.00
|
|
BUY
|
| DHH28807B |
Research Grade Afasevikumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHE07706A |
Research Grade Anrukinzumab |
100 ug |
$380.00
|
|
BUY
|
| DHE07706B |
Research Grade Anrukinzumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DVV11801B |
Research Grade Anti-HPV18 L1/Major capsid protein L1 (H18L1-A) mAb |
1.0 mg |
$1,715.00
|
|
BUY
|
| DVV11801A |
Research Grade Anti-HPV18 L1/Major capsid protein L1 (H18L1-A) mAb |
100 µg |
$475.00
|
|
BUY
|
| DHD06901B |
Research Grade Anti-Human CD122/IL2RB (Mik beta 1) |
1.0 mg |
$1,560.00
|
|
BUY
|
| DHD06901A |
Research Grade Anti-Human CD122/IL2RB (Mik beta 1) |
100 ug |
$430.00
|
|
BUY
|
| DHF68801B |
Research Grade Anti-Human CD156b/ADAM17 (MEDI3622) |
1.0 mg |
$1,715.00
|
|
BUY
|
| DHF68801A |
Research Grade Anti-Human CD156b/ADAM17 (MEDI3622) |
100 ug |
$475.00
|
|
BUY
|
| DHJ89810A |
Research Grade Anti-Human CD357/TNFRSF18/GITR (REGN 6569) |
100 ug |
$475.00
|
|
BUY
|
| DHJ89810B |
Research Grade Anti-Human CD357/TNFRSF18/GITR (REGN 6569) |
100 ug |
$1,715.00
|
|
BUY
|
| RGK60602A |
Research Grade Anti-Human GP6/GPVI (hu9O12.2) mAb |
100 ug |
$430.00
|
|
BUY
|
| DHJ05001A |
Research Grade Anti-Human IL31 (BMS-981164) |
100 ug |
$475.00
|
|
BUY
|
| DHJ05001B |
Research Grade Anti-Human IL31 (BMS-981164) |
1.0 mg |
$1,715.00
|
|
BUY
|
| DHD29901A |
Research Grade Anti-Human ITGB6 (SGN-B6A) |
100 ug |
$475.00
|
|
BUY
|
| DHD29901B |
Research Grade Anti-Human ITGB6 (SGN-B6A) |
1.0 mg |
$1,715.00
|
|
BUY
|
| DHK13704B |
Research Grade Anti-Human SIGLEC15/CD33L3 (DS1501) mAb |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHK13704A |
Research Grade Anti-Human SIGLEC15/CD33L3 (DS1501) mAb |
100 µg |
$420.00
|
|
BUY
|
| DHK23201B |
Research Grade Anti-Human TNFRSF25 (PTX-35) mAb |
1.0 mg |
$1,715.00
|
|
BUY
|
| DHK23201A |
Research Grade Anti-Human TNFRSF25 (PTX-35) mAb |
100 µg |
$475.00
|
|
BUY
|
| DVV00317A |
Research Grade Anti-SARS-CoV-2 Spike-RBD (S2H97) mAb |
100 µg |
$420.00
|
|
BUY
|
| DVV00317B |
Research Grade Anti-SARS-CoV-2 Spike-RBD (S2H97) mAb |
1.0 mg |
$1,520.00
|
|
BUY
|
| DVV00317B-BT |
Research Grade Anti-SARS-CoV-2 Spike-RBD (S2H97) mAb, Biotin labeled |
1.0 mg |
$2,310.00
|
|
BUY
|
| DVV00317X-BT |
Research Grade Anti-SARS-CoV-2 Spike-RBD (S2H97) mAb, Biotin labeled |
0.5 mg |
$1,485.00
|
|
BUY
|
| DHC34001A |
Research Grade Apamistamab |
100 ug |
$380.00
|
|
BUY
|
| DHC34001B |
Research Grade Apamistamab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHD47201A |
Research Grade Avdoralimab |
100 ug |
$380.00
|
|
BUY
|
| DHD47201B |
Research Grade Avdoralimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHJ59401A |
Research Grade Avizakimab |
100 ug |
$380.00
|
|
BUY
|
| DHJ59401B |
Research Grade Avizakimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHJ64002A |
Research Grade Azintuxizumab |
100 ug |
$380.00
|
|
BUY
|
| DHJ64002B |
Research Grade Azintuxizumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHD47901A |
Research Grade Bemarituzumab |
100 ug |
$380.00
|
|
BUY
|
| DHD47901B |
Research Grade Bemarituzumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHB95501A |
Research Grade Bermekimab |
100 ug |
$380.00
|
|
BUY
|
| DHB95501B |
Research Grade Bermekimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHD98101B |
Research Grade Besilesomab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHD98101A |
Research Grade Besilesomab |
100 ug |
$380.00
|
|
BUY
|
| DHD12602B |
Research Grade Bevacizumab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHD12602A |
Research Grade Bevacizumab |
100 ug |
$420.00
|
|
BUY
|
| DXX00301B |
Research Grade Bezlotoxumab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DXX00301A |
Research Grade Bezlotoxumab |
100 µg |
$420.00
|
|
BUY
|
| DHH28803B |
Research Grade Bimekizumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHH28803A |
Research Grade Bimekizumab |
100 ug |
$380.00
|
|
BUY
|
| DHD14801A |
Research Grade Bivatuzumab |
100 ug |
$380.00
|
|
BUY
|
| DHD14801B |
Research Grade Bivatuzumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHH02210A |
Research Grade Budigalimab |
100 ug |
$380.00
|
|
BUY
|
| DHH02210B |
Research Grade Budigalimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHD14203A |
Research Grade Cantuzumab |
100 ug |
$380.00
|
|
BUY
|
| DHD14203B |
Research Grade Cantuzumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHC97801A |
Research Grade Carlumab |
100 ug |
$430.00
|
|
BUY
|
| DHC97801B |
Research Grade Carlumab |
1.0 mg |
$1,560.00
|
|
BUY
|
| DHE07701A |
Research Grade Cendakimab |
100 ug |
$380.00
|
|
BUY
|
| DHE07701B |
Research Grade Cendakimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHC21002A |
Research Grade Cergutuzumab |
100 ug |
$420.00
|
|
BUY
|
| DHC21002B |
Research Grade Cergutuzumab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHD17401A |
Research Grade Citatuzumab |
100 ug |
$380.00
|
|
BUY
|
| DHD17401B |
Research Grade Citatuzumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHC15805A |
Research Grade Clazakizumab |
100 ug |
$380.00
|
|
BUY
|
| DHC15805B |
Research Grade Clazakizumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHD14205A |
Research Grade Clivatuzumab |
100 ug |
$380.00
|
|
BUY
|
| DHD14205B |
Research Grade Clivatuzumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHD10801A |
Research Grade Coltuximab |
100 ug |
$420.00
|
|
BUY
|
| DHD10801B |
Research Grade Coltuximab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHA29103A |
Research Grade Conatumumab |
100 ug |
$380.00
|
|
BUY
|
| DHA29103B |
Research Grade Conatumumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHE43204A |
Research Grade Cudarolimab |
100 ug |
$380.00
|
|
BUY
|
| DHE43204B |
Research Grade Cudarolimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHD68908A |
Research Grade Dacetuzumab |
100 ug |
$380.00
|
|
BUY
|
| DHD68908B |
Research Grade Dacetuzumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHE07707B |
Research Grade Dectrekumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHE07707A |
Research Grade Dectrekumab |
100 ug |
$380.00
|
|
BUY
|
| DHD10805A |
Research Grade Denintuzumab |
100 ug |
$420.00
|
|
BUY
|
| DHD10805B |
Research Grade Denintuzumab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DGK07801A |
Research Grade Dinutuximab |
100µg |
$405.00
|
|
BUY
|
| DGK07801B |
Research Grade Dinutuximab |
1mg |
$1,505.00
|
|
BUY
|
| DHC09603A |
Research Grade Disitamab |
100 ug |
$380.00
|
|
BUY
|
| DHC09603B |
Research Grade Disitamab |
1.0 mg |
$1,380.00
|
|
BUY
|
